Understanding and treating aggressive prostate cancer
UCSF Specialized Programs of Research Excellence (SPOREs) in Prostate Cancer
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-10769613
This study is looking into prostate cancer to find out what makes it aggressive and to develop better treatments, so men facing this disease can have more effective options and improved outcomes.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-10769613 on ClinicalTrials.gov |
What this research studies
This research focuses on prostate cancer, which is a leading cause of cancer deaths among men in the U.S. The UCSF Prostate Cancer SPORE aims to reduce the impact of this disease by exploring its biological mechanisms and developing new treatment strategies. The team will investigate the molecular drivers of aggressive prostate cancer, create biomarkers to guide treatment, and address therapeutic resistance in advanced cases. Through collaborative and transdisciplinary approaches, the research seeks to translate scientific findings into effective clinical applications.
Who could benefit from this research
Good fit: Ideal candidates for this research include men diagnosed with advanced or aggressive prostate cancer, particularly those with metastatic castration-resistant prostate cancer.
Not a fit: Patients with early-stage prostate cancer or those without a diagnosis of prostate cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and outcomes for patients with aggressive prostate cancer.
How similar studies have performed: Previous research has shown promise in similar approaches to understanding and treating prostate cancer, indicating potential for success in this area.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SMALL, ERIC J — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: SMALL, ERIC J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Cause